does blue cross blue shield of texas cover glp 1 and October 2025 Performance Drug List obesity #tippingpointinobesitycare #joenadglowski #oac #jennyseger

Having daily or weekly injections of GLP-1 agonists such as Ozempic and Wegovy may become a thing of the past for people with diabetes if a new drug delivery system proves effective in humans.

However, innovations in drug delivery have sparked interest in alternatives like the GLP-1 patch

Targeted Probiotic Support: Our formula delivers targeted probiotic support to enhance the growth of beneficial gut bacteria, aiding in nutrient absorption and digestive comfort

Our guide explains GLP-1 patches and their benefits for balanced living

This analysis in #JCOOP showed a nearly 30% drop in incidencefrom 2.3% to 1.6% and it has generated a lot of discussion

The war is on between compounding pharmacies making knockoff versions of popular weight loss drugs and pharma giants Novo Nordisk and Eli Lilly, who want to protect their right to sell their patent | Novo Nordisk has asked the FDA to prevent compounders from manufacturing copycat versions of its juggernaut diabetes and obesity treatments Ozempic and Wegovy, claiming the drugs are too complex to safely replicate.